The role of VEGF and other parameters in tracking the clinical course in metronomic chemotherapy. [electronic resource]
Producer: 20130626Description: 245-52 p. digitalISSN:- 1107-0625
- Administration, Metronomic
- Adult
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bevacizumab
- Biomarkers, Tumor -- blood
- Camptothecin -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Leucovorin -- administration & dosage
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Neoplasms -- blood
- Time Factors
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- blood
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.